Skip to main content

Table 2 Clinical characteristics of the ΔM-CSF-high and the ΔM-CSF-low groups at the end of follow-up

From: Association of plasma macrophage colony-stimulating factor with cardiovascular morbidity and all-cause mortality in chronic hemodialysis patients

Variables

â–³M-CSF-low group

â–³M-CSF-high group

p value

Number

22

22

 

Male (%)

50%

68%

0.220

Age (Y)

57.14 ± 15.51

55.64 ± 19.24

0.777

Hemodialysis duration (months)

93.97 ± 43.17

82.59 ± 36.27

0.349

Diabetes (%)

13.6%

22.7%

0.434

Predialysis Hb (g/L)

112.18 ± 11.04

101.00 ± 18.97

0.021

Predialysis serum creatinine (μmol/L)

970.79 ± 209.40

1111.50 ± 242.59

0.049

Predialysis serum urea nitrogen (mmol/L)

25.67 ± 5.00

30.08 ± 6.69

0.020

Predialysis serum uric acid (μmol/L)

466.00 (436.50,512.00)

465.00 (406.80,554.00)

0.966

Predialysis K (mmol/L)

5.10 ± 0.80

4.96 ± 0.96

0.582

Predialysis Ca (mmol/L)

2.46 (2.12–2.53)

2.30 (2.16–2.48)

0.425

Predialysis P (mmol/L)

2.07 ± 0.55

2.18 ± 0.62

0.318

Predialysis IPTH (ng/L)

384.40 (153.40,688.00)

536.30 (243.68,1595.00)

0.049

Predialysis Systolic BP (mmHg)

147.00 (123.00,162.50)

140.00 (118.30,160.00)

0.527

Predialysis Diastolic BP (mmHg)

82.10 ± 13.51

80.73 ± 13.56

0.742

Predialysis Mean BP (mmHg)

102.06 ± 14.70

99.76 ± 14.46

0.607

  1. M-CSF macrophage colony- stimulating factor, Hb hemoglobin, IPTH intact parathyroid hormone, BP blood pressure